Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |